The Advisors Asset Management Inc. Has $4,831,000 Position in PNC Financial Services Group Inc. (PNC)

The Advisors Asset Management Inc. Has $4,831,000 Position in PNC Financial Services Group Inc. (PNC)

Advisors Asset Management Inc. decreased its position in PNC Financial Services Group Inc. (NYSE:PNC) by 12.8% during the third quarter, Holdings Channel reports. The institutional investor owned 53,626 shares of the company’s stock after selling 7,860 shares during the period. Advisors Asset Management Inc.’s holdings in PNC Financial Services Group were worth $4,831,000 as of its most recent SEC filing. Other institutional investors have also bought and sold shares of the company. Quadrant Capital Group LLC raised its position in PNC Financial Services Group by 3.9% in the third quarter….

The Tocqueville Asset Management L.P. Sells 24,565 Shares of Vertex Pharmaceuticals Inc. (VRTX)

The Tocqueville Asset Management L.P. Sells 24,565 Shares of Vertex Pharmaceuticals Inc. (VRTX)

Tocqueville Asset Management L.P. lowered its stake in shares of Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) by 43.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 32,466 shares of the pharmaceutical company’s stock after selling 24,565 shares during the period. Tocqueville Asset Management L.P.’s holdings in Vertex Pharmaceuticals were worth $2,831,000 as of its most recent filing with the SEC. Several other large investors also recently made changes to their positions in VRTX. Manning & Napier Advisors LLC increased its…

The Tesaro Inc. (TSRO) Shares Bought by Tocqueville Asset Management L.P.

The Tesaro Inc. (TSRO) Shares Bought by Tocqueville Asset Management L.P.

Tocqueville Asset Management L.P. boosted its stake in shares of Tesaro Inc. (NASDAQ:TSRO) by 18.6% during the third quarter, Holdings Channel reports. The institutional investor owned 37,650 shares of the biopharmaceutical company’s stock after buying an additional 5,900 shares during the period. Tocqueville Asset Management L.P.’s holdings in Tesaro were worth $3,774,000 at the end of the most recent quarter. Other institutional investors have also recently added to or reduced their stakes in the company. CenturyLink Investment Management Co purchased a new position in Tesaro during the third quarter valued…

The Fortuna Silver Mines Inc. (FSM) Shares Sold by Tocqueville Asset Management L.P.

The Fortuna Silver Mines Inc. (FSM) Shares Sold by Tocqueville Asset Management L.P.

Tocqueville Asset Management L.P. reduced its stake in shares of Fortuna Silver Mines Inc. (NYSE:FSM) (TSE:FVI) by 2.3% during the third quarter, Holdings Channel reports. The fund owned 514,000 shares of the company’s stock after selling 12,000 shares during the period. Tocqueville Asset Management L.P.’s holdings in Fortuna Silver Mines were worth $3,726,000 at the end of the most recent reporting period. Other hedge funds have also recently bought and sold shares of the company. Shell Asset Management Co. increased its stake in Fortuna Silver Mines by 8.8% in the…

The FY2017 Earnings Forecast for Diamondback Energy Inc. Issued By Capital One Financial Corp. (FANG)

The FY2017 Earnings Forecast for Diamondback Energy Inc. Issued By Capital One Financial Corp. (FANG)

Diamondback Energy Inc. (NASDAQ:FANG) – Investment analysts at Capital One Financial Corp. upped their FY2017 EPS estimates for Diamondback Energy in a note issued to investors on Thursday. Capital One Financial Corp. analyst R. Tullis now expects that the brokerage will earn $2.71 per share for the year, up from their prior forecast of $2.18. Diamondback Energy (NASDAQ:FANG) last released its earnings results on Monday, November 7th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.20. Diamondback Energy had a…

The Impax Laboratories Inc. (IPXL) Receives Average Recommendation of “Hold” from Analysts

The Impax Laboratories Inc. (IPXL) Receives Average Recommendation of “Hold” from Analysts

Impax Laboratories Inc. (NASDAQ:IPXL) has received an average recommendation of “Hold” from the eighteen analysts that are currently covering the company. Two research analysts have rated the stock with a sell recommendation, eleven have issued a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $26.36. Several equities research analysts recently weighed in on the company. RBC Capital Markets restated a “sector perform” rating and set…

The Anglo American plc (NGLOY) Upgraded by HSBC Holdings plc to “Buy”

The Anglo American plc (NGLOY) Upgraded by HSBC Holdings plc to “Buy”

HSBC Holdings plc upgraded shares of Anglo American plc (NASDAQ:NGLOY) from a hold rating to a buy rating in a research note issued to investors on Tuesday. NGLOY has been the topic of a number of other reports. Citigroup Inc. upgraded Anglo American plc from a sell rating to a neutral rating in a research report on Monday, December 5th. BNP Paribas upgraded Anglo American plc from an underperform rating to a neutral rating in a research report on Friday, December 2nd. Anglo American plc (NASDAQ:NGLOY) opened at 7.92 on…

The Eni SpA (E) Raised to Buy at Jefferies Group

The Eni SpA (E) Raised to Buy at Jefferies Group

Jefferies Group upgraded shares of Eni SpA (NYSE:E) from a hold rating to a buy rating in a research report report published on Tuesday morning. A number of other research analysts also recently commented on E. Zacks Investment Research raised shares of Eni SpA from a sell rating to a hold rating in a research report on Friday, September 23rd. Deutsche Bank AG raised shares of Eni SpA from a hold rating to a buy rating in a research report on Wednesday, October 5th. Citigroup Inc. reaffirmed a buy rating…

The Investment Analysts’ Weekly Ratings Updates for Ladbrokes Coral Group PLC (LCL)

The Investment Analysts’ Weekly Ratings Updates for Ladbrokes Coral Group PLC (LCL)

A number of firms have modified their ratings and price targets on shares of Ladbrokes Coral Group PLC (LON: LCL) recently: Shares of Ladbrokes Coral Group PLC (LON:LCL) opened at 126.40 on Monday. Ladbrokes Coral Group PLC has a 52-week low of GBX 126.30 and a 52-week high of GBX 128.13. The company’s market cap is GBX 1.29 billion. The company has a 50 day moving average of GBX 0.00 and a 200-day moving average of GBX 0.00. In other news, insider Mark Clare purchased 50,000 shares of the business’s…

The PZ Cussons plc (PZC) Scheduled to Post Earnings on Tuesday

The PZ Cussons plc (PZC) Scheduled to Post Earnings on Tuesday

PZ Cussons plc (LON:PZC) is set to release its earnings data on Tuesday, January 24th. Shares of PZ Cussons plc (LON:PZC) opened at 334.60 on Monday. The company’s market cap is GBX 1.40 billion. The company’s 50-day moving average price is GBX 325.28 and its 200 day moving average price is GBX 335.69. PZ Cussons plc has a one year low of GBX 240.70 and a one year high of GBX 374.60. A number of brokerages have recently commented on PZC. Numis Securities Ltd lowered shares of PZ Cussons plc…

The Booker Group Plc (BOK) – Research Analysts’ Weekly Ratings Changes

The Booker Group Plc (BOK) – Research Analysts’ Weekly Ratings Changes

Booker Group Plc (LON: BOK) recently received a number of ratings updates from brokerages and research firms: Shares of Booker Group Plc (LON:BOK) opened at 184.50 on Monday. The stock has a 50 day moving average of GBX 175.25 and a 200 day moving average of GBX 176.34. Booker Group Plc has a 12 month low of GBX 151.80 and a 12 month high of GBX 192.00. The firm’s market cap is GBX 3.26 billion. Booker Group plc is a food wholesaler. The Company operates through wholesaling activities segment. The…

The National Express Group PLC (NEX) – Research Analysts’ Recent Ratings Updates

The National Express Group PLC (NEX) – Research Analysts’ Recent Ratings Updates

A number of firms have modified their ratings and price targets on shares of National Express Group PLC (LON: NEX) recently: National Express Group PLC (LON:NEX) opened at 339.40 on Monday. The firm’s market capitalization is GBX 1.73 billion. National Express Group PLC has a one year low of GBX 252.81 and a one year high of GBX 379.10. The stock’s 50 day moving average price is GBX 351.54 and its 200-day moving average price is GBX 348.46. National Express Group PLC is a public transport operator with bus, coach…

The Rothschild Asset Management Inc. Invests $266,000 in USANA Health Sciences Inc. (USNA)

The Rothschild Asset Management Inc. Invests $266,000 in USANA Health Sciences Inc. (USNA)

Rothschild Asset Management Inc. purchased a new position in USANA Health Sciences Inc. (NYSE:USNA) during the third quarter, Holdings Channel reports. The fund purchased 1,922 shares of the company’s stock, valued at approximately $266,000. Several other institutional investors also recently added to or reduced their stakes in USNA. Old Mutual Global Investors UK Ltd. raised its position in USANA Health Sciences by 52.8% in the third quarter. Old Mutual Global Investors UK Ltd. now owns 90,316 shares of the company’s stock valued at $12,495,000 after buying an additional 31,211 shares…

The Alambic Investment Management L.P. Has $137,000 Stake in MoneyGram International Inc. (MGI)

The Alambic Investment Management L.P. Has $137,000 Stake in MoneyGram International Inc. (MGI)

Alambic Investment Management L.P. increased its stake in MoneyGram International Inc. (NASDAQ:MGI) by 10.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,315 shares of the company’s stock after buying an additional 1,900 shares during the period. Alambic Investment Management L.P.’s holdings in MoneyGram International were worth $137,000 at the end of the most recent quarter. A number of other large investors also recently bought and sold shares of the company. Panagora Asset Management Inc….

The Alambic Investment Management L.P. Raises Stake in Limelight Networks Inc. (LLNW)

The Alambic Investment Management L.P. Raises Stake in Limelight Networks Inc. (LLNW)

Alambic Investment Management L.P. raised its position in Limelight Networks Inc. (NASDAQ:LLNW) by 39.4% during the third quarter, Holdings Channel reports. The firm owned 59,440 shares of the company’s stock after buying an additional 16,800 shares during the period. Alambic Investment Management L.P. owned about 0.06% of Limelight Networks worth $111,000 as of its most recent filing with the SEC. Several other hedge funds have also bought and sold shares of the company. BlackRock Fund Advisors increased its position in shares of Limelight Networks by 21.8% in the second quarter….

The Perrigo Co. (PRGO) Price Target Lowered to $85.00 at Royal Bank Of Canada

The Perrigo Co. (PRGO) Price Target Lowered to $85.00 at Royal Bank Of Canada

Perrigo Co. (NYSE:PRGO) had its target price reduced by Royal Bank Of Canada from $92.00 to $85.00 in a research report released on Tuesday. They currently have a sector perform rating on the stock. PRGO has been the subject of several other reports. RBC Capital Markets set a $92.00 target price on Perrigo and gave the company a hold rating in a report on Monday, October 24th. JPMorgan Chase & Co. set a $95.00 price target on Perrigo and gave the stock a hold rating in a report on Thursday,…

The Michaels Cos. (MIK) Upgraded to “Overweight” by Morgan Stanley

The Michaels Cos. (MIK) Upgraded to “Overweight” by Morgan Stanley

Morgan Stanley upgraded shares of Michaels Cos. (NASDAQ:MIK) from an equal weight rating to an overweight rating in a research report released on Tuesday. They currently have $25.00 price target on the stock. The analysts noted that the move was a valuation call. A number of other research analysts have also recently commented on the stock. Bank of America Corp. cut shares of Michaels Cos. from a buy rating to a neutral rating in a research report on Friday, November 4th. Zacks Investment Research cut shares of Michaels Cos. from…

The Navient Corp. (NAVI) Rating Lowered to Neutral at JPMorgan Chase & Co.

The Navient Corp. (NAVI) Rating Lowered to Neutral at JPMorgan Chase & Co.

JPMorgan Chase & Co. lowered shares of Navient Corp. (NASDAQ:NAVI) from an overweight rating to a neutral rating in a report issued on Tuesday morning. They currently have $19.00 price target on the stock. Other analysts have also recently issued research reports about the stock. Barclays PLC set a $21.00 target price on shares of Navient Corp. and gave the company a buy rating in a research note on Sunday, January 8th. Credit Suisse Group AG cut shares of Navient Corp. from an outperform rating to a neutral rating and…

The Meridian Bioscience Inc. (VIVO) Upgraded to Hold at Zacks Investment Research

The Meridian Bioscience Inc. (VIVO) Upgraded to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Meridian Bioscience Inc. (NASDAQ:VIVO) from a sell rating to a hold rating in a research note released on Tuesday morning. According to Zacks, “Meridian is a fully integrated life sciences company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, urinary and respiratory infections….

The Lexicon Pharmaceuticals Inc. (LXRX) Lowered to “Sell” at Zacks Investment Research

The Lexicon Pharmaceuticals Inc. (LXRX) Lowered to “Sell” at Zacks Investment Research

Zacks Investment Research lowered shares of Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) from a hold rating to a sell rating in a report released on Tuesday. According to Zacks, “Lexicon Genetics Incorporated is a leader in defining the functions of genes for drug discovery using large-scale knockout mouse technology. Lexicon has invented high-throughput gene trapping technology to discover thousands of genes and expand its OmniBank library of tens of thousands of mouse clones. The Company uses an integrated platform of functional genomic technologies to accelerate large-scale analysis of mammalian gene function for…